28.51% +0.69

Genprex Inc (GNPX)

Genprex Inc Borsa (GNPX) Ultime notizie

Genprex Inc (GNPX)

Genprex Inc Borsa (GNPX) Ultime notizie

Genprex (GNPX) Shares Surge Ahead Of Prominent Convention – News IMC - News IMC

Genprex to Present at the 2024 BIO International Convention - PR Newswire

GNPX Stock Earnings: Genprex Beats EPS for Q1 2024 - InvestorPlace

HC Wainwright Reaffirms “Buy” Rating for Genprex (NASDAQ:GNPX) - Defense World

Genprex doses first subject in lung cancer therapy trial - Clinical Trials Arena

John Rodney Varner - Burleson County Tribune |

Genprex doses first subject in lung cancer therapy trial - Clinical Trials Arena

Genprex dosing subjects in trial of combination therapy for small-cell lung cancer - Yahoo Finance

Genprex doses first subject in lung cancer therapy trial - Clinical Trials Arena

Clinical Trials Commenced for Promising Acclaim-3 Reqorsa Registered Immunogene Therapy in Combination with ... - openPR

Clinical Trials Commenced for Promising Acclaim-3 Reqorsa® Immunogene Therapy in Combination with Tecentriq ... - WICZ

Clinical Trials Commenced for Immunogene Therapy: Advancing Small Cell Lung Cancer Treatment : Genprex; - EIN News

Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa® Immunogene Therapy in Combination with ... - Nasdaq

Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa® Immunogene Therapy in Combination with ... - PR Newswire

New Company Officers Appointed After Promising Preclinical Data on Gene Therapy for Anti-Tumor Mechanisms with ... - openPR

New Company Officers Appointed After Promising Preclinical Data on Gene Therapy for Anti-Tumor Mechanisms with ... - WICZ

Genprex names Jose Moreno Toscano as Board Chairman - Investing.com Canada

Genprex names Jose Moreno Toscano as Board Chairman - Investing.com

Genprex names Jose Moreno Toscano as Board Chairman - Investing.com UK

New Company Officers Appointed After Promising Preclinical Data on Gene Therapy for Anti-Tumor Mechanisms - EIN News

Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors - StreetInsider.com

Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors - Nasdaq

New Company Officers Appointed After Promising Preclinical Data on Gene Therapy for Anti-Tumor Mechanisms - EIN News

John Rodney Varner Obituary - Austin American-Statesman

Genprex (GNPX) Up on Advancing Early-Stage NSCLC Study - Yahoo Canada Shine On

Genprex Co-Founder, CEO Rodney Varner Dies of Cancer - MarketWatch

Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner - Lelezard

Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner - Longview News-Journal

Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner - Investing.com South Africa

Genprex Co-Founder, CEO Rodney Varner Dies of Cancer - MarketWatch

John Varner Obituary - Austin, TX - Dignity Memorial

Genprex (NASDAQ:GNPX) Trading 5.3% Higher - Defense World

Are Insiders Buying Genprex, Inc. (NASDAQ:GNPX) Stock? - Yahoo Movies Canada

Genprex to Present and Participate at Upcoming May Investor and Industry Conferences - BioSpace

Genprex to Present and Participate at Upcoming May Investor and Industry Conferences - Yahoo Finance

Genprex reports promising lung cancer therapy results By Investing.com - Investing.com Nigeria

Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing ... - PR Newswire

Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up

Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up - Zacks Investment Research

Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq ... - PR Newswire

Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System - PR Newswire

H.C. Wainwright starts Genprex stock at Buy on cancer gene therapy By Investing.com - Investing.com

Genprex Shares Drop 12% on Latest Stock Offering to Get Proceeds of $5.8M - MarketWatch

Genprex Shares Hit 52-Week Low After Direct Offering Prices - MarketWatch

Genprex Receives Notice of Patent Grant for Korean Patent Claiming Reqorsa® Immunogene Therapy with PD-1 and ... - PR Newswire

Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Genprex Expands Nonclinical Programs into New Therapeutic Indications with Research Collaborators - PR Newswire

Genprex Launches Phase 2a Reqorsa Trial Expansion - TipRanks.com - TipRanks

Genprex Announces First Patient Dosed in Phase 2a Expansion of Acclaim-1 Clinical Study of Reqorsa® Therapy in ... - PR Newswire

Genprex Inc Announces Reverse Stock Split and Fiscal Changes - TipRanks.com - TipRanks

Simile a GNPX